Mechanical circulatory support has evolved dramatically in the last 30 years and has
become a mainstay in the treatment of cardiogenic shock and advanced heart failure. As a …

Monitoring of the patient supported with a temporary mechanical circulatory support (tMCS)
is crucial in achieving the best possible outcome. Monitoring is a continuous and labour …

Various devices for MCS in cardiogenic shock are available, but routine use is not supported
by high-quality randomized evidence. Given the resources required for initiation of MCS, use …

The comment concerns two short-term assist systems, namely the Impella axial-flow
recovery system and extra-corporeal membrane oxygenation (ECMO) used for circulatory …

Aims Mechanical circulatory support (MCS) systems are increasingly employed in
cardiogenic shock and advanced heart failure. A thorough understanding of the complex …

Cardiogenic shock (CS) represents one of the foremost concerns in the field of acute
cardiovascular medicine. Despite major advances in treatment, mortality of CS remains high …

Cardiogenic shock following acute myocardial infarction affects 5% to10% of patients and
carries a grave prognosis. The dismal prognosis associated with post‐MI cardiogenic shock …

Background The aim of this study was to evaluate mechanical circulatory support (MCS) for
the treatment of non-ischemic cardiogenic shock (CS). Methods Data from 1,030 …

Percutaneous mechanical circulatory support (MCS) strategies have been in the clinical
arena for approximately half a century, with the main aim of providing adequate systemic …

Despite advancements in algorithms concerning the management of cardiogenic shock,
current guidelines still lack the adequate integration of mechanical circulatory support …